TOP 008
Alternative Names: TOP-008Latest Information Update: 06 Jan 2021
At a glance
- Originator Nippon Chemiphar
- Developer Hitachi Chemical; Nippon Chemiphar; Nonindustrial source
- Class Antineoplastics; Piperazines
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 11 Dec 2007 Discontinued - Preclinical for Cancer in USA (unspecified route)
- 06 Mar 2001 Preclinical development for Cancer in Japan (Unknown route)
- 06 Mar 2001 Preclinical development for Cancer in USA (Unknown route)